Autophagy regulates β-hydroxybutyrate synthesis to prevent hypertension-associated premature vascular aging
自噬调节β-羟基丁酸合成以预防高血压相关的血管过早老化
基本信息
- 批准号:10516445
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Hypertension is a condition of premature vascular aging, relative to actual chronological age. In fact, many factors
that contribute to the deterioration of vascular function as we age are accelerated and exacerbated in hypertension.
Nonetheless, our understanding of the mechanisms that cause arteries to prematurely age, thus increasing the
cardiovascular risk for hypertensive patients, is yet to be determined. It is well established that the
upregulation/reconstitution of autophagy ameliorates the aged phenotype, especially in the vasculature. Nonetheless,
the precise mechanisms by which autophagy exerts anti-vascular aging effects, remain to be elucidated. Therefore,
the long-term objective of this project is to uncover novel mechanisms by which autophagy ameliorates premature
vascular aging associated with hypertension. Evolutionarily, autophagy serves to mobilize macro - and micronutrients
in times of starvation and stress. As a result, autophagy has also been recognized as a mediator of hepatic lipid
metabolism, which could then liberate substrates for ketogenesis. Previously, we made the seminal observation that
autophagy induces the biosynthesis of liver-derived ketone body, -hydroxybutyrate (OHB). Furthermore, we have
observed that OHB has profound anti-hypertensive effects, including potent vasodilation of isolated resistance
arteries, however, data collected from the K99 phase has suggested that this is through a non -canonical signaling
mechanism. Therefore, we hypothesize that upregulation of autophagy in liver, stimulates the production of OHB,
which induces vasodilation, and decreases phenotypes of premature vascular aging associated with hypertension. We
will test this hypothesis by executing the following specific aims: 1) OHB prevents vascular aging phenotypes by
stimulating vasodilation via direct activation of potassium channels on endothelial cells, and 2) decreased autophagic
activity in hypertension reduces OHB biosynthesis, contributing to high blood pressure and premature vascular
aging. To execute these aims, we will investigate mice genetically deficient in specific potassium channels, mice
genetically deficient in autophagy protein Atg5, and genetically hypertensive rats. Hypertension will be induced in mice
via angiotensin II infusion. Collectively, this application proposes a novel, physiologic mechanism by which autophagy
in the liver prevents premature vascular aging and also proposes a pathogenic consequence of decreased autophagic
activity in hypertension. As vascular age is a new clinically used index for cardiovascular disease risk, understanding
these mechanisms may assist in the development of new therapies to reverse or prevent vascular damage associated
with hypertension. Given that hypertension is a major public health burden in the United States, our proposal is very
much in accordance with the mission of the National Institutes of Health.
相对于实际年代年龄,高血压是过早血管衰老的条件。实际上,许多因素
随着年龄的增长,这有助于血管功能的定义,并在高血压中加剧和加剧。
但是,我们对导致动脉过早年龄的机制的理解,从而增加
高血压患者的心血管风险尚未确定。众所周知,
自噬的上调/重建可以改善老化的表型,尤其是在脉管系统中。尽管如此,
自噬出口抗血管老化作用的确切机制仍有待阐明。所以,
该项目的长期目标是揭示自动噬来改善早产的新型机制
与高血压相关的血管衰老。进化上,自噬可动员宏观和微量营养素
在饥饿和压力的时期。结果,自噬也被认为是肝脂质的介体
代谢,它可以解放酮基底物以进行生酮发生。以前,我们进行了第二个观察,
自噬诱导了活酮体的生物合成OHB(OHB)。此外,我们还有
观察到◎ohb具有深刻的抗高血压作用,包括分离抗性的有效血管舒张
然而,动脉从K99阶段收集的数据表明,这是通过非规范信号传导
机制。因此,我们假设肝脏自噬的上调刺激了◎OHB的产生,
这会诱导血管舒张,并增加与高血压相关的过早血管衰老的表型。我们
将通过执行以下特定目的来检验这一假设:1)OHB通过
通过直接激活内皮细胞上的钾通道来刺激血管舒张,2)精制自噬
高血压的活性降低了OHB生物合成,有助于高血压和过早血管
老化。为了执行这些目标,我们将研究小鼠在特定钾通道中的小鼠,小鼠
在遗传上缺乏自噬蛋白ATG5和遗传性高血压大鼠。小鼠将诱导高血压
通过血管紧张素II输注。总的来说,该应用程序提出了一种新颖的生理机制,该机制是自噬的
在肝脏中可防止过早的血管老化,还提出了自噬减少的致病结果
高血压的活性。由于血管年龄是一种新的临床使用指数,用于心血管疾病风险,因此了解
这些机制可能有助于开发新的疗法,以逆转或预防与血管损伤相关
高血压。鉴于高血压是美国的主要公共卫生伯恩顿,我们的提议非常
与国家卫生研究院的使命相符。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cameron McCarthy其他文献
Cameron McCarthy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cameron McCarthy', 18)}}的其他基金
Autophagy regulates β-hydroxybutyrate synthesis to prevent hypertension-associated premature vascular aging
自噬调节β-羟基丁酸合成以预防高血压相关的血管过早老化
- 批准号:
10541254 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
调节聚焦理论视角下企业环境战略选择机制及其绩效影响研究
- 批准号:72362031
- 批准年份:2023
- 资助金额:27 万元
- 项目类别:地区科学基金项目
傣药芽命几及单体异鼠李素调节蛋白合成-分解代谢治疗骨骼肌萎缩的作用及机制研究
- 批准号:82305431
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
长效HBV衣壳组装调节剂的设计合成及抗病毒活性研究
- 批准号:82304288
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
HIF-2α介导Müller调节神经细胞凋亡的缺血性视网膜病变机制研究
- 批准号:82371077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
胆汁酸通过LXR-β调节肝内2型固有淋巴细胞的数量和功能影响NASH相关肝纤维化的进程研究
- 批准号:82300706
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
How blood vessel stiffness regulates their growth and maintenance
血管硬度如何调节其生长和维持
- 批准号:
DE240101055 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Discovery Early Career Researcher Award
Determining how sub-cellular localisation of interleukin-1alpha regulates immunity.
确定 IL-1α 的亚细胞定位如何调节免疫。
- 批准号:
BB/Y004876/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
Elucidation of autophagy receptor that regulates programmed nuclear death of Tetrahymena
阐明调节四膜虫程序性核死亡的自噬受体
- 批准号:
23K05756 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
- 批准号:
10520211 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
NHERF1 regulates MRGPRX2/MrgprB2 responses in mast cells
NHERF1 调节肥大细胞中的 MRGPRX2/MrgprB2 反应
- 批准号:
10711042 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别: